These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection.ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial useInitial U.S. Approval: 1995

Patient Home

Welcome to Health Vidya. Discover trusted care and your own health — all in one place.

These highlights do not include all the information needed to use ULTRAVIST Injection safely and effectively. See full prescribing information for ULTRAVIST Injection.ULTRAVIST (iopromide) Injection, for intravenous or intra-arterial useInitial U.S. Approval: 1995

Medication label

Why this: Advisory · dailymed-prescription

ULTRAVIST® Injection is an iodinated contrast agent indicated for: ULTRAVIST is indicated for: •Cerebral arteriography and peripheral arteriography in adults •Coronary arteriography and left ventriculography, visceral angiography, and aortography in adults •Radiographic evaluation of cardiac chambers and related arteries in pediatric patients aged 2 years and older ULTRAVIST is indicated for: •Excretory urography in adults and pediatric patients aged 2 years and older •Contrast Computed Tomography (CT) of the head and body (intrathoracic, intra-abdominal, and retroperitoneal regions) for the evaluation of neoplastic and non-neoplastic lesions in adults and pediatric patients aged 2 years and older •Contrast mammography to visualize known or suspected lesions of the breast in adults, as an adjunct following mammography and/or ultrasound †Specific concentrations and presentations of ULTRAVIST are recommended for each type of imaging procedure [see Dosage and Administration ( 2.2, 2.3, 2.4)].

generic_name: iopromide
product_names: iopromide
ndc: 50419-342, 50419-342-41, 50419-342-10, 50419-342-05, 50419-342-43, 50419-342-21, 50419-344, 50419-344-12, 50419-344-10, 50419-344-07, 50419-344-05, 50419-344-41, 50419-344-43, 50419-344-91, 50419-344-15, 50419-344-21, 50419-344-48, 50419-344-97, 50419-344-23, 50419-344-65, 50419-344-32, 50419-344-58, 50419-346, 50419-346-20, 50419-346-15, 50419-346-10, 50419-346-07, 50419-346-05, 50419-346-12, 50419-346-41, 50419-346-43, 50419-346-45, 50419-346-91, 50419-346-33, 50419-346-58, 50419-346-32, 50419-346-26, 50419-346-97, 50419-346-65, 50419-346-28, 50419-348, 50419-348-10, 50419-348-11, 50419-348-20, 50419-348-05, 50419-348-12, 50419-348-13, 50419-348-21, 50419-347, 50419-347-05, 50419-347-20
group: drugs
license: us-gov-pd
attribution: Courtesy of the National Library of Medicine
reviewed: 2026-09-18
language: en